313 related articles for article (PubMed ID: 37329216)
1. Adipose Tissue Dysfunction in Polycystic Ovary Syndrome.
Bril F; Ezeh U; Amiri M; Hatoum S; Pace L; Chen YH; Bertrand F; Gower B; Azziz R
J Clin Endocrinol Metab; 2023 Dec; 109(1):10-24. PubMed ID: 37329216
[TBL] [Abstract][Full Text] [Related]
2. Adipose tissue dysfunction in polycystic ovary syndrome.
Villa J; Pratley RE
Curr Diab Rep; 2011 Jun; 11(3):179-84. PubMed ID: 21424395
[TBL] [Abstract][Full Text] [Related]
3. Peri-muscular adipose tissue may play a unique role in determining insulin sensitivity/resistance in women with polycystic ovary syndrome.
Morrison SA; Goss AM; Azziz R; Raju DA; Gower BA
Hum Reprod; 2017 Jan; 32(1):185-192. PubMed ID: 27827322
[TBL] [Abstract][Full Text] [Related]
4. Inflammatory cytokines and chemokines, skeletal muscle and polycystic ovary syndrome: effects of pioglitazone and metformin treatment.
Ciaraldi TP; Aroda V; Mudaliar SR; Henry RR
Metabolism; 2013 Nov; 62(11):1587-96. PubMed ID: 23958241
[TBL] [Abstract][Full Text] [Related]
5. Adipose tissue dysfunction, adipokines, and low-grade chronic inflammation in polycystic ovary syndrome.
Spritzer PM; Lecke SB; Satler F; Morsch DM
Reproduction; 2015 May; 149(5):R219-27. PubMed ID: 25628442
[TBL] [Abstract][Full Text] [Related]
6. Metabolic dysfunction in polycystic ovary syndrome: Pathogenic role of androgen excess and potential therapeutic strategies.
Sanchez-Garrido MA; Tena-Sempere M
Mol Metab; 2020 May; 35():100937. PubMed ID: 32244180
[TBL] [Abstract][Full Text] [Related]
7. Alterations in nonesterified free fatty acid trafficking rather than hyperandrogenism contribute to metabolic health in obese women with polycystic ovary syndrome.
Ezeh U; Chen YI; Pall M; Buyalos RP; Chan JL; Pisarska MD; Azziz R
Fertil Steril; 2024 Jun; 121(6):1040-1052. PubMed ID: 38307453
[TBL] [Abstract][Full Text] [Related]
8. Metabolism and insulin signaling in common metabolic disorders and inherited insulin resistance.
Højlund K
Dan Med J; 2014 Jul; 61(7):B4890. PubMed ID: 25123125
[TBL] [Abstract][Full Text] [Related]
9. Alterations in plasma non-esterified fatty acid (NEFA) kinetics and relationship with insulin resistance in polycystic ovary syndrome.
Ezeh U; Arzumanyan Z; Lizneva D; Mathur R; Chen YH; Boston RC; Chen YI; Azziz R
Hum Reprod; 2019 Feb; 34(2):335-344. PubMed ID: 30576500
[TBL] [Abstract][Full Text] [Related]
10. Novel insights into the synergistic effects of selenium nanoparticles and metformin treatment of letrozole - induced polycystic ovarian syndrome: targeting PI3K/Akt signalling pathway, redox status and mitochondrial dysfunction in ovarian tissue.
Rabah HM; Mohamed DA; Mariah RA; Abd El-Khalik SR; Khattab HA; AbuoHashish NA; Abdelsattar AM; Raslan MA; Farghal EE; Eltokhy AK
Redox Rep; 2023 Dec; 28(1):2160569. PubMed ID: 36661246
[TBL] [Abstract][Full Text] [Related]
11. Insulin resistance in skeletal muscle and adipose tissue in polycystic ovary syndrome: are the molecular mechanisms distinct from type 2 diabetes?
Corbould A
Panminerva Med; 2008 Dec; 50(4):279-94. PubMed ID: 19078869
[TBL] [Abstract][Full Text] [Related]
12. Polycystic Ovary Syndrome as a Proinflammatory State: The Role of Adipokines.
Dimitriadis GK; Kyrou I; Randeva HS
Curr Pharm Des; 2016; 22(36):5535-5546. PubMed ID: 27464726
[TBL] [Abstract][Full Text] [Related]
13. Polycystic ovary syndrome and adipose tissue.
Lemaitre M; Christin-Maitre S; Kerlan V
Ann Endocrinol (Paris); 2023 Apr; 84(2):308-315. PubMed ID: 36623807
[TBL] [Abstract][Full Text] [Related]
14. Chinese herbal medicine alleviates the pathogenesis of polycystic ovary syndrome by improving oxidative stress and glucose metabolism via mitochondrial Sirtuin 3 signaling.
Zhang Q; Ren J; Wang F; Li M; Pan M; Zhang H; Qu F
Phytomedicine; 2023 Jan; 109():154556. PubMed ID: 36610149
[TBL] [Abstract][Full Text] [Related]
15. Adipocyte Insulin Resistance in PCOS: Relationship With GLUT-4 Expression and Whole-Body Glucose Disposal and β-Cell Function.
Ezeh U; Chen IY; Chen YH; Azziz R
J Clin Endocrinol Metab; 2020 Jul; 105(7):e2408-20. PubMed ID: 32382742
[TBL] [Abstract][Full Text] [Related]
16. Adipocyte expression of glucose transporter 1 and 4 in PCOS: Relationship to insulin-mediated and non-insulin-mediated whole-body glucose uptake.
Ezeh U; Chen IY; Chen YH; Azziz R
Clin Endocrinol (Oxf); 2019 Apr; 90(4):542-552. PubMed ID: 30623452
[TBL] [Abstract][Full Text] [Related]
17. Metabolic consequences of obesity and insulin resistance in polycystic ovary syndrome: diagnostic and methodological challenges.
Jeanes YM; Reeves S
Nutr Res Rev; 2017 Jun; 30(1):97-105. PubMed ID: 28222828
[TBL] [Abstract][Full Text] [Related]
18. Nutrient-Induced Inflammation in Polycystic Ovary Syndrome: Role in the Development of Metabolic Aberration and Ovarian Dysfunction.
González F
Semin Reprod Med; 2015 Jul; 33(4):276-86. PubMed ID: 26132932
[TBL] [Abstract][Full Text] [Related]
19. Serum metabolomics profiling by proton nuclear magnetic resonance spectrometry of the response to single oral macronutrient challenges in women with polycystic ovary syndrome (PCOS) compared with male and female controls.
Escobar-Morreale HF; Martínez-García MÁ; Insenser M; Cañellas N; Correig X; Luque-Ramírez M
Biol Sex Differ; 2023 Sep; 14(1):62. PubMed ID: 37736753
[TBL] [Abstract][Full Text] [Related]
20. Adipocyte and steroidogenic cell cross-talk in polycystic ovary syndrome.
de Medeiros SF; Rodgers RJ; Norman RJ
Hum Reprod Update; 2021 Jun; 27(4):771-796. PubMed ID: 33764457
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
